Keisha Hylton-Rodic, Ph.D., Esq.
Keisha Hylton-Rodic, Ph.D. is a registered patent attorney with a Ph.D. in Organic Chemistry. She specializes in assisting pharmaceutical companies, start-ups, universities, chemical companies, and venture capital funds, achieve their IP objectives. Dr. Hylton-Rodic’s practice includes patent procurement, patent-related risk assessments (including freedom-to-operate, IP due diligence investigations, non-infringement, and validity), design-around strategies and opinions. She has extensive experience developing and managing domestic and foreign patent portfolios in a variety of technical areas including biotech, chemical, pharmaceutical, food, and paper.
Dr. Hylton-Rodic received alternative dispute resolution training through the Florida Dispute Resolution Center and was certified by the Florida Supreme Court as a county court mediator.
Dr. Hylton-Rodic’s doctoral research focused on W(CO)6-catalyzed carbonylation as an alternative to phosgene or phosgene derivatives such as 1,1-carbonyldiimidazole (CDI) for the conversion of amines to ureas. Specifically, her research included preparing the core structure of the HIV protease inhibitors DMP 323 and DMP 450 by catalytic carbonylation of diamine intermediates. Her research also included intermolecular urea formation in related acyclic systems by catalytic carbonylation of O-protected phenylalaninol derivatives and W(CO)6-catalyzed carbonylation as successfully applied to the preparation of analogs of DMP 323 and DMP 450. Her research further included carbonylating amino alcohols to selectively form hydroxyl ureas.
Dr. Hylton-Rodic is actively involved in the legal community. She served as a judge 2008-2010 at the American Bar Association (ABA) Law Student Division’s National Appellate Advocacy (NAAC) Competitions, Washington DC Regional. She also graded Briefs for the 2009 American Intellectual Property Law Association (AIPLA)’s Giles Sutherland Moot Court Competition.
She is also actively involved in the IP Law Section of the ABA (ABA-IPL) where she currently serves as Chair of ABA-IPL’s USPTO Affairs (Post Grant and Inter Partes) Committee and serves as a member of the Life Sciences Working Group. Dr. Hylton-Rodic is also Liaison to the ABA Health Law Section and ABA Health Law Coordinating Group, respectively.
She previously served as a member of the ABA-IPL Task Force on Reverse Settlement Payments in Pharma Litigation and ABA-IPL Task Force on Proposed USPTO Ethics Rules, respectively. Dr. Hylton-Rodic is immediate past chair of Patents in the Chemical and Life Sciences Committee.
2013 Recognition of Outstanding Leadership Contribution (American Bar Association (ABA), Section of Intellectual Property Law)
2017 Recognition of Outstanding Leadership Contribution (American Bar Association (ABA), Section of Intellectual Property Law)
Speaking Engagements and Publications
Working with SPEs: Best Practices Guide for Life Sciences Patent Practitioners, ACI’s Advanced Summit on Life Sciences Patents (January 2014)
The Nuts & Bolts of Patents and Drug Approval (ABA-IPL Webinar, November 2013)
Reverse Payments Update: Key Strategies to Bring to the Settlement Table, American Conference Institute (July 2013)
Patent Procurement In The Age Of Harmonization: Strategies For Building A Solid Global Patent Portfolio, ABA-IPL Spring Conference 2013
Single Claim Restriction Webinar
A Patent Law Primer For Start-Ups seminar, Peninsula Technology, Hampton, VA (January 2013)
Recent Developments in Patent Term Adjustments and Extensions, ABA-IPL Spring Conference 2012
Intensive Deep-Dive into the Orphan Drug Act: Demystifying the Designation Process and Discovering the Accompanying Incentives, ACI Orphan Drugs and Rare Diseases Conference (November 2012)
Cutting Edge Issues Surrounding Pharmaceuticals and Patents, Sixth Annual Intellectual Property Law Seminar (March 2009)
Larson Mfg. Co. v. Aluminart Products Ltd.: Did the Federal Circuit Break New Ground in Inequitable Conduct? Maryland State Bar Association
Diaz, D.J., Hylton, K-G. McElwee-White, L., "Catalytic Oxidative Carbonylation of Amino Alcohols," Journal of Organic Chemistry, 2006, 71, 734-738.
Hylton, K-G., Main, A.D., McElwee-White, L., "Catalytic Carbonylation of Functionalized Diamines: Application to the Core Structure of DMP 323 and DMP 450," Journal of Organic Chemistry, 2003, 68, 1615-1617
Ji, Y., Fang, Y., Tymoshenko, D., Hylton, K-G, Katrizky, A.R., "The Synthesis of 2, 3, 5-Trisubstituted Phenols," ARKIVOC, 2001, 4, 20-28